Documente Academic
Documente Profesional
Documente Cultură
H .Q. NAME :
Page 1 of 4
DELHI POOL
14
9/3/2013
1 AMTAS-10 15 TAB
2 AMTAS-2.5 15 TAB
3 AMTAS-5 15 TAB
AMTAS GRP
4 AMTAS HT 10 TAB
AMTAS HT GRP
5 AMTAS LP 10 TAB
AMTAS LP GRP
6 BISELECT-2.5 10 TAB
7 BISELECT-5 10 TAB
8 BISELECT-10 10 TAB.
BISELECT GRP
9
10
11
12
CARCA 25 10 TAB
CARCA 12.5 10 TAB
CARCA 3.125 15 TAB
CARCA 6.25 15 TAB
CARCA GRP
19 EMBETA AM 25 10 TAB
20 EMBETA AM 50 10 TAB
EMBETA AM GRP
21 EMBETA-100 10 TAB
22 EMBETA-25 10 TAB
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales
(Units)
Achi.
(%)
Variance
(+/-)
Growth
(%)
YPM
2521
5864
17549
2960
6603
21094
117
113
120
439
739
3545
7326
17041
50996
5273
12222
39539
72
72
78
-2053
-4819
-11457
12695
29529
88347
13073
29929
96434
103
101
109
378
400
8087
18
14
10
187
428
1378
983192
1104279
112
121087
2857106
2058433
72
-798673
4950090
5168786
104
218697
12
73840
1060
860
81
-200
3079
1780
58
-1299
5338
5430
102
92
78
21582
17508
81
-4074
62688
36237
58
-26451
108682
110136
101
1455
1573
485
240
49
-245
1411
760
54
-651
2444
2160
88
-284
-19
31
18653
9230
49
-9423
54267
29112
54
-25155
93996
82950
88
-11046
-19
1185
528
137
23
40
160
40
8
117
174
-488
23
17
1534
396
67
80
390
40
5
98
60
-1454
-6
-27
2657
687
117
3490
3980
110
131
579
94
833
3293
-7
56
359
-21
50
57
2
10352
4675
45
-5677
30046
9093
30
-20953
52094
111848
215
59754
141
1598
898
2639
8811
5431
1190
3457
9210
5180
133
131
105
95
292
818
399
-251
2611
7669
25605
15782
2325
7167
19315
10280
89
93
75
65
-286
-502
-6290
-5502
4523
13290
44367
27347
5945
17222
48584
27012
131
130
110
99
1422
3932
4217
-335
8
19
43
22
85
246
694
386
546728
586746
107
40018
1588867
1199885
76
-388982
2753120
3032462
110
279343
26
43321
14656
8356
14110
7980
96
96
-546
-376
42588
24279
28470
14450
67
60
-14118
-9829
73795
42072
72935
38380
99
91
-860
-3692
-2
-5
1042
548
661403
593346
90
-68058
1921869
1180483
61
-741386
3330211
3123865
94
-206346
-3
44627
394
156
9500
447
90
8480
113
58
89
53
-66
-1020
1144
455
27606
1037
150
17186
91
33
62
-107
-305
-10420
1985
789
47834
2487
610
46336
125
77
97
502
-179
-1498
40
-30
-4
36
9
662
638768
569575
89
-69192
1856181
1159928
62
-696253
3216467
3109222
97
-107244
-2
44417
98
90
92
-8
286
170
59
-116
495
480
97
-15
-25
3848
3534
92
-314
11231
6675
59
-4556
19439
18773
97
-665
-25
268
537
2546
670
3060
125
120
133
514
1561
7399
1200
5699
77
77
-361
-1700
2706
12820
3380
14734
125
115
674
1914
13
25
48
210
142070
170618
120
28548
412890
316816
77
-96074
715452
827215
116
111762
23
11817
21
639
0
440
0
69
-21
-199
60
1858
0
830
0
45
-60
-1028
104
3220
0
2110
0
66
-104
-1110
-100
-44
0
30
Page 2 of 4
DELHI POOL
14
9/3/2013
23 EMBETA-50 10 TAB
EMBETA GRP
24 EMBETA HT 25 10 TAB
25 EMBETA HT 50 10 TAB
EMBETA HT GRP
26
27
28
29
EMBETA XR GRP
30 EPTIBA 20MG/10ML
31 EPTIBA 75MG/100ML
EPTIBA GRP
32 LOPARIN 20MG/0.2ML
33 LOPARIN 40MG/0.4ML
34 LOPARIN 60MG/0.6ML
LOPARIN GRP
36 TEROFIB 100ML
TEROFIB GRP
37 URIBID 15 TAB
URIBID GRP
38
39
40
41
ZOREM GRP
42 ZOREM HT 10 TAB
43 ZOREM HT-5 10 TAB
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales
(Units)
Achi.
(%)
Variance
(+/-)
Growth
(%)
YPM
281
340
121
59
817
560
69
-257
1417
1645
116
228
-9
24
11507
9990
87
-1517
33432
17536
52
-15896
57958
48433
84
-9526
-32
692
5
52
0
0
0
0
-5
-52
15
151
0
100
0
66
-15
-51
26
263
0
240
0
91
-26
-23
-100
0
0
3
2379
-2379
6925
4252
61
-2673
12056
10204
85
-1853
-3137
146
1036
6758
7692
233
1015
6847
7850
310
98
101
102
133
-21
89
158
77
3009
19639
22351
677
2275
14523
17000
660
76
74
76
97
-734
-5116
-5351
-17
5216
34030
38732
1172
5990
36253
45034
1240
115
107
116
106
774
2223
6302
68
29
46
47
0
86
518
643
18
942662
953829
101
11166
2739132
2053914
75
-685218
4746626
5319614
112
572988
46
75994
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
738
999
0
131
1170
0
18
117
-10
-607
171
30
2144
2904
0
1969
3240
0
92
112
-30
-175
336
51
3716
5033
0
5145
8376
0
138
166
-51
1429
3343
-100
2
35
0
74
120
269155
212305
79
-56850
782320
812148
104
29828
1355785
2104457
155
748672
21
30064
1194
1390
116
196
3471
3060
88
-411
6013
5720
95
-293
82
57312
71958
126
14646
166608
154526
93
-12082
288624
282294
98
-6330
4033
127
69
54
-58
370
259
70
-111
642
831
129
189
10
12
133350
72453
54
-60897
388500
270728
70
-117772
674100
870059
129
195959
10
12429
1346
1470
109
124
3913
3730
95
-183
6780
7934
117
1154
28
113
135986
148520
109
12534
395330
374561
95
-20770
684983
794737
116
109753
28
11353
65
1093
576
442
40
1110
1410
480
62
102
245
109
-25
17
834
38
189
3175
1674
1284
60
2085
2865
1010
32
66
171
79
-129
-1090
1191
-274
327
5503
2902
2226
250
5995
7744
2720
76
109
267
122
-77
492
4842
494
-40
-5
-17
7
4
86
111
39
160987
181387
113
20400
467729
361111
77
-106618
810774
982373
121
171599
-9
14034
107
414
220
360
206
87
113
-54
312
1203
450
930
144
77
138
-273
540
2085
1060
2620
196
126
520
535
-15
2
15
37
Page 3 of 4
DELHI POOL
14
9/3/2013
Target
(Units)
ZOREM HT GRP
53
54
55
56
LOSARTAS GRP
GORUP 1
57 O-BETA 25MG 14 TAB
58 O-BETA 50MG 14 TAB
OBETA GRP
59 ZORYL MP LD 1 10 TAB
60 ZORYL MP LD 2 10 TAB
ZORYL MP LD GRP
(H)
(H)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Sales
(Units)
Achi.
(%)
Variance
(+/-)
Growth
(%)
YPM
34750
31853
92
-2897
101061
77502
77
-23558
175097
209179
119
34082
-2
2988
6
36
0
30
0
83
-6
-6
18
105
0
70
0
67
-18
-35
31
181
0
170
0
94
-31
-11
0
4
0
2
2612
1941
74
-671
7643
4530
59
-3113
13173
11001
84
-2173
157
1047
658
170
1340
670
180
128
102
106
293
12
10
3042
1913
493
2780
1305
290
91
68
59
-262
-608
-203
5271
3315
855
6720
3535
925
127
107
108
1449
220
70
63
41
36
96
51
13
97881
110641
113
12759
284369
214160
75
-70208
492833
560725
114
67892
49
8010
1521
3619
2109
3117
139
86
588
-502
4419
10516
1592
2474
36
24
-2827
-8042
7659
18221
5275
11274
69
62
-2384
-6947
-24
-27
75
161
468059
458432
98
-9628
1360022
356616
26
-1003407
2356673
1477961
63
-878711
-26
21114
110
553
160
230
145
42
50
-323
318
1606
-50
-91
-16
-6
-368
-1697
551
2783
287
1579
52
57
-264
-1204
-41
-30
4
23
36142
20235
56
-15907
104893
-7385
-7
-112278
181764
100801
55
-80963
-32
1440
1
290
292
358
0
405
506
262
0
140
173
73
-1
115
214
-96
3
842
847
1039
0
735
941
472
0
87
111
45
-3
-107
94
-567
5
1460
1469
1801
0
2340
7811
1622
0
160
532
90
-5
880
6342
-179
0
-8
216
-30
0
33
112
23
55291
40979
74
-14312
160466
83886
52
-76580
278237
529008
190
250770
73
7557
5434671
5374031
99
-60640
15793575
10774745
68
-5018830
27368234
28886103
106
1517869
13
412659
0
0
80
100
0
0
80
100
0
0
115
150
0
0
115
150
0
0
710
2390
0
0
710
2390
1
262
10
34
2412
2412
3564
3564
44665
44665
150
638
142
341
-14
-9
-10
-3
-156
-350
412
993
-137
-144
-33
-15
-549
-1137
714
1721
63
296
9
17
-651
-1425
-95
-78
1
4
23630
-1050
-4
-24679
68747
-13181
-19
-81928
119146
18004
15
-101142
-85
257
189
114
60
-75
549
174
32
-375
951
1904
200
953
16
27
12431
7426
60
-5004
36108
11335
31
-24773
62547
115565
185
53018
16
1651
108
43
-50
-20
-46
-47
-158
-63
315
125
-70
-40
-22
-32
-385
-165
546
216
-30
10
-5
5
-576
-206
0
0
0
0
Page 4 of 4
DELHI POOL
14
9/3/2013
EMBETA R GRP
64 EMBETA-TM 25 10 TAB
65 EMBETA-TM 50 10 TAB
EMBETA TM GRP
66 TRIZORYL 1 10 TAB
67 TRIZORYL 2 10 TAB
TRIZORYL GRP
GROUP 2
Target
(Units)
Sales Achi.
(Units)
(%)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales
(Units)
Achi.
(%)
Variance
(+/-)
Growth
(%)
YPM
-5058
-47
-15933
31678
-8246
-26
-39924
54844
-901
-2
-55745
-13
0
0
280
370
0
0
280
370
0
0
470
690
0
0
470
690
0
0
1520
1810
0
0
1520
1810
0
0
22
26
45663
45663
81486
81486
232333
232333
3319
0
0
980
980
0
0
980
980
0
0
980
980
0
0
980
980
0
0
980
980
0
0
980
980
0
0
14
14
91675
91675
91675
91675
91675
91675
1310
46935
141068
301
94133
136533
166634
122
30100
236537
501341
212
264804
108
7162
5481606
5515098
101
33493
15930109
10941379
69
-4988730
27604771
29387445
106
1782673
14
419821
5568304
StockiestSales
5090532
53206
Target
(Units)
10875
Variance
(+/-)
53206
5515098
424567
5515098
IMP Notes:
1. All Decimals below 0.5 will be deemed as the lower whole number and above 0.5 as the higher whole number while calculating percentages.
2. Variance is the minimum balance to be achieved to earn full quarters' incentive before deductions like Sales Returns, RGRR and Outstanding Amount if any.
3. In order to arrive at the NET SALES figure for incentive calculation, it is mandatory to deduct (as per incentive circular) outstanding amount & other deduction
including two times salable returns and single time deduction in case goods are recalled from H.O. or cancellation of invoice due to system/human error.
4. In case any query/discripancy noticed, please inform within a week time through your reporting Manager/Executive for checking and taking corrective action.